Contact our responsive and friendly client services team any time.
(03) 9028 2888
clients@freshequities.com
INVESTOR PRESENTATION - Anatara Lifesciences Ltd
Health
Anatara Lifesciences Ltd (ANR) is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Company's initial focus is the development and commercialisation of Detach, which is a natural, plant-based, non-antibiotic therapy that prevents and treats diarrhoea in pigs.
Read moreMarket Cap
Price at Close
4w avg. Volume
4w avg. Turnover
announcement | t+2 movement | date |
---|---|---|
| -10.53% | 14 Dec 2020 |
| 0.00% | 07 Dec 2020 |
| 0.00% | 03 Dec 2020 |
| 0.00% | 03 Dec 2020 |
| 0.00% | 03 Dec 2020 |
| 0.00% | 03 Dec 2020 |
| 0.00% | 03 Dec 2020 |
| -5.13% | 29 Nov 2020 |
| 0.00% | 26 Nov 2020 |
| 0.00% | 26 Nov 2020 |
Current Price
52WK HIGH
52WK LOW
1YR RETURN
1YR RETURN VS. SECTOR
90 DAY RETURN
ASX RANK
/2,047
SECTOR RANK
/168
SHARES OUTSTANDING
Health
Anatara Lifesciences Ltd (ANR) is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Company's initial focus is the development and commercialisation of Detach, which is a natural, plant-based, non-antibiotic therapy that prevents and treats diarrhoea in pigs.
Read moreMarket Cap
Price at Close
4w avg. Volume
4w avg. Turnover
ASX:ANR is not raising right now
Want to invest?
(03) 9028 2888
clients@freshequities.com
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia